Clinical Focus ›› 2016, Vol. 31 ›› Issue (4): 352-354.doi: 10.3969/j.issn.1004-583X.2016.04.002

Previous Articles     Next Articles

New anticoagulants and clinical application of venous thromboembolism

Yang Yuanhua1, Yang Suqiao1,Zhang Mingyuan2   

  1. 1.Department of Respirology and Critical Medicne, Beijing Chaoyang Hospital, Capital Medical University,Beijing Institute of Respiratory Medicine, Beijing 100020,China;
    2.Department of Respiratory Medicine,Tianjin Haihe Hospital,Tianjin 300350,China
  • Received:2016-01-15 Online:2016-04-05 Published:2016-04-18
  • Contact: Yang Yuanhua,Email: yyh1031@sina.com

Abstract: In China, the new anticoagulants, which mainly include two categories: factor Ⅹa inhibitors and factor Ⅱa inhibitors, have been gradually applied in the treatment of venous thromboembolism (VTE). This article illustrates the results of clinical study, application methods and cautions of VTE treatments that employed various new anticoagulants for better clinical using of these drugs and getting best effect of therapy.

Key words: venous thrombosis, anticoagulants, antithrombin Ⅲ, hemorrhage

CLC Number: